Omega Therapeutics Inc (OMGA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Mahesh Karande
Employees:
120
20 ACORN PARK DRIVE, CAMBRIDGE, MA 02140
(617) 949-4360

Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechani® for gene control and cell differentiation. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 362.64 Million Shares Outstanding48.095 Million Avg 30-day Volume 89.566 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.22
Price to Revenue131.5306 Debt to Equity0.1622 EBITDA-102.791 Million
Price to Book Value2.482 Operating Margin-4680.0948 Enterprise Value188.441 Million
Current Ratio8.222 EPS Growth-3.723 Quick Ratio7.582
1 Yr BETA 1.5928 52-week High/Low 11.98 / 2.05 Profit Margin-4645.2391
Operating Cash Flow Growth-46.678 Altman Z-Score1.8673 Free Cash Flow to Firm -81.759 Million
Earnings Report2023-08-03
View SEC Filings from OMGA instead.

View recent insider trading info

Omega Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding OMGA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OMGA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-05-03 by YOUNG RICHARD A
  • 4: filed on 2023-04-10 by YOUNG RICHARD A
  • 4: filed on 2023-03-20 by YOUNG RICHARD A
  • 4: filed on 2023-03-02 by MOORE YAN
  • 4: filed on 2023-03-02 by MCMANUS KEVIN
  • 4: filed on 2023-03-02 by KARANDE MAHESH
  • 4: filed on 2023-03-02 by ZENG LING
  • 4: filed on 2023-03-02 by REED JOSHUA
  • 4: filed on 2023-02-27 by AFEYAN NOUBAR
  • 3: filed on 2023-02-27 by Flagship Pioneering Fund VII, L.P.

    • Events (8k)

  • 8-K: filed on 2023-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-08:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2022-10-12:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-06-02:
  • 144: filed on 2023-05-01:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    10 Thousand total shares from 2 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    YOUNG RICHARD A

    • Director
    		 739,118 2023-06-02 7

    REED JOSHUA CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-02-28 2

    ZENG LING SEE REMARKS

    • Officer
    		 0 2023-02-28 2

    MCCAULEY THOMAS CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2023-02-28 2

    KARANDE MAHESH PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2023-02-28 2

    MOORE YAN CHIEF MEDICAL OFFICER

    • Officer
    		 0 2023-02-28 2

    MCMANUS KEVIN CHIEF HUMAN RESOURCES OFFICER

    • Officer
    		 0 2023-02-28 2

    FLAGSHIP PIONEERING INC.

    FLAGSHIP PIONEERING SPECIAL OPPORTUNITIES FUND II GENERAL PARTNER LLC

    FLAGSHIP PIONEERING SPECIAL OPPORTUNITIES FUND II, L.P.

    AFEYAN NOUBAR

    • Director
    • 10% Owner
    		 29,225,579 2023-02-27 2

    FLAGSHIP PIONEERING FUND VII GENERAL PARTNER LLC

    FLAGSHIP PIONEERING FUND VII, L.P.

    • 10% Owner
    		 1,329,324 2023-02-27 1

    BOEHM RAINER J.

    • Director
    		 0 2022-08-31 2

    BESHAR LUKE M

    • Director
    		 18,118 2022-06-08 1

    AFEYAN NOUBAR

    • Director
    • 10% Owner
    		 18,118 2022-06-08 2

    MENDLEIN JOHN

    • Director
    		 18,118 2022-06-08 1

    SZELA MARY T

    • Director
    		 18,118 2022-06-08 1

    LEVY ELLIOTT M.

    • Director
    		 18,118 2022-06-08 1

    SAWHNEY ROGER CHIEF FINANCIAL OFFICER

    • Officer
    		 60,000 2022-03-09 0

    BERRY DAVID A

    • Director
    		 53,082 2021-08-03 0

    FLAGSHIP PIONEERING INC.

    FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLC

    FLAGSHIP PIONEERING FUND VI, L.P.

    FLAGSHIP PIONEERING SPECIAL OPPORTUNITIES FUND II, L.P.

    FLAGSHIP PIONEERING SPECIAL OPPORTUNITIES FUND II GENERAL PARTNER LLC

    NUTRITIONAL HEALTH LTP FUND, L.P.

    NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

    FPN GENERAL PARTNER LLC

    FPN, L.P.

    AFEYAN NOUBAR

    • Director
    • 10% Owner
    		 25,902,269 2021-08-03 2

    FLAGSHIP PIONEERING INC.

    FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC

    FLAGSHIP V VENTURELABS RX FUND, L.P.

    FLAGSHIP VENTURES FUND V, L.P.

    FLAGSHIP VENTURELABS V MANAGER LLC

    FLAGSHIP VENTURELABS V LLC

    • 10% Owner
    		 25,902,269 2021-08-03 0

    INVUS PUBLIC EQUITIES, L.P.

    ARTAL INTERNATIONAL S.C.A.

    ARTAL INTERNATIONAL MANAGEMENT S.A.

    ARTAL GROUP S.A.

    WESTEND S.A.

    WITTOUCK AMAURY

    STICHTING ADMINISTRATIEKANTOOR WESTEND

    ARTAL TREASURY LTD

    INVUS PUBLIC EQUITIES ADVISORS, LLC

    • 10% Owner
    		 2,273,530 2021-07-30 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    YOUNG RICHARD A - Director

    		2023-06-05 16:15:06 -0400 2023-06-02 S 5,000 $8.00 d 739,118 direct yes

    YOUNG RICHARD A - Director

    		2023-05-03 16:05:22 -0400 2023-05-01 S 5,000 $8.00 d 744,118 direct yes 9.4293 1.861 9.4293 2 -1.2407 5

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 22:15:03 UTC -1.1337 6.2037 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 21:45:05 UTC -1.1337 6.2037 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 21:15:04 UTC -1.1337 6.2037 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 20:45:04 UTC -1.1337 6.2037 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 20:15:04 UTC -1.1337 6.2037 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 19:45:04 UTC -1.1337 6.2037 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 19:15:03 UTC -1.1337 6.2037 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 18:45:04 UTC -1.1337 6.2037 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 18:15:04 UTC -1.1337 6.2037 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 17:45:04 UTC -1.1337 6.2037 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 17:15:04 UTC -1.1337 6.2037 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 16:45:04 UTC -1.1328 6.1928 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 16:15:03 UTC -1.1328 6.1928 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 15:45:04 UTC -1.1328 6.1928 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 15:15:04 UTC -1.1328 6.1928 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 14:45:04 UTC -1.1109 6.1709 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 14:15:03 UTC -1.1109 6.1709 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 13:45:03 UTC -1.1109 6.1709 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 13:15:03 UTC -1.1109 6.1709 450000
    OMEGA THERAPEUTICS INC OMGA 2023-06-06 12:45:05 UTC -1.1109 6.1709 450000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund OMGA -400.0 shares, $-2412.0 2023-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments